Nrf2 activators as attractive therapeutics for diabetic nephropathy

Diabetes

Volumn 60, Issue 11, 2011, Pages 2683-2684

  De Haan, Judy B ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BARDOXOLONE METHYL; CAFFEIC ACID PHENETHYL ESTER; CINNAMALDEHYDE; EBSELEN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2;

CHRONIC KIDNEY DISEASE; DEFENSE MECHANISM; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FIBROSIS; KIDNEY FUNCTION; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; RENAL PROTECTION; UPREGULATION;

ACROLEIN; ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; NF-E2-RELATED FACTOR 2; THIOCYANATES;

EID: 80755168955     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1072     Document Type: Note

References (17)

1. Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med 2010;268:456-467
2. Mann JF, Schmieder RE, McQueen M, et al.; ONTARGET investigators. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, doubleblind, controlled trial. Lancet 2008;372:547-553
3. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2009;4:542-551
4. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007;47:89-116
5. Chan K, Han XD, Kan YW. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc Natl Acad Sci USA 2001;98:4611-4616 (Pubitemid 32295024)
6. Thomas M, Cooper ME. Bardoxolone improves kidney function in patients with type 2 diabetes. Nat Rev Nephrol. In press
7. Sakurai T, Kanayama M, Shibata T, et al. Ebselen, a seleno-organic antioxidant, as an electrophile. Chem Res Toxicol 2006;19:1196-1204 (Pubitemid 44454036)
8. Xue M, Qian Q, Adaikalakoteswari A, Rabbani N, Babaei-Jadidi R, Thornalley PJ. Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 2008;57:2809-2817
9. Lee Y, Shin DH, Kim JH, et al. Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition. Eur J Pharmacol 2010;643:21-28
10. Dinkova-Kostova AT, Liby KT, Stephenson KK, et al. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci U S A 2005;102:4584-4589 (Pubitemid 40397155)
11. Yates MS, Tauchi M, Katsuoka F, et al. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol Cancer Ther 2007;6:154-162 (Pubitemid 46206678)
12. Zheng H, Whitman SA, Wu W, et al. Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 2011;60: 3055-3066
13. Kobayashi M, Li L, Iwamoto N, et al. The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol Cell Biol 2009;29:493-502
14. Holland R, Hawkins AE, Eggler AL, Mesecar AD, Fabris D, Fishbein JC. Prospective type 1 and type 2 disulfides of Keap1 protein. Chem Res Toxicol 2008;21:2051-2060
15. Pergola PE, Raskin P, Toto RD, et al.; BEAM Study Investigators. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 2011;365:327-336
16. Brenner BM, Cooper ME, de Zeeuw D, et al.; RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-869
17. Jung KA, Kwak MK. The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules 2010;15:7266-7291